Viewing Study NCT01883492


Ignite Creation Date: 2025-12-24 @ 3:44 PM
Ignite Modification Date: 2025-12-24 @ 3:44 PM
Study NCT ID: NCT01883492
Status: TERMINATED
Last Update Posted: 2020-02-17
First Post: 2013-01-31
Is Possible Gene Therapy: False
Has Adverse Events: True

Brief Title: A Prospective Multi-center Study on Total Hip Arthroplasty With E1
Sponsor: Zimmer Biomet
Organization:

Study Overview

Official Title: A Prospective Multi-center Randomized Study on Total Hip Replacement With E1
Status: TERMINATED
Status Verified Date: 2020-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Enrollment of the subject could not reach statistically required number.
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The primary objectives of this clinical study include:

* Evaluate E1 Wear including early bedding-in process, clinical outcomes on patients who received Total Hip Arthroplasty with E1
* Compare E1 wear used with CoCr and Biolox Delta heads
Detailed Description: This study is designed as PROSPECTIVE, RANDOMIZED, MULTI-CENTER Study to compare two different materials (CoCr and Delta ceramic) articulating against E1 Highly Crosslinked polyethylene in Hip Replacement.

Patient population is 160 (80 each). Follow-up period is 10 year postoperatively. E1 liners with thickness of 4.8mm at 45 degrees position (load bearing direction) will be used in all cases.

Randomization will occur via random number generator by 4 blocks randomization.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: True
Is an FDA AA801 Violation?: